Home
FBIOP
FBIOP News

Latest Fortress Biotech Inc. (FBIOP) News on July 26, 2024

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

GlobeNewswire

a day ago

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

GlobeNewswire

2 days ago

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

Argus Research

11 days ago

Daily – Vickers Top Buyers & Sellers for 07/16/2024

Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)

Zacks

11 days ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

GlobeNewswire

11 days ago

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

GlobeNewswire

15 days ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

GlobeNewswire

21 days ago

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

24 days ago

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

GlobeNewswire

25 days ago

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

GlobeNewswire

a month ago

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a month ago

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire

a month ago

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a month ago

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

GlobeNewswire

a month ago

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a month ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a month ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a month ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a month ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

a month ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

a month ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

a month ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

a month ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

GlobeNewswire

2 months ago

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

2 months ago

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

Associated Press Finance

2 months ago

Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

2 months ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates

Zacks

2 months ago

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

MT Newswires

2 months ago

Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

GlobeNewswire

2 months ago

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

2 months ago

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

GlobeNewswire

3 months ago

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire

3 months ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Mustang Bio Announces Closing of $4 Million Public Offering

GlobeNewswire

3 months ago

Mustang Bio Announces Closing of $4 Million Public Offering

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

GlobeNewswire

3 months ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

Mustang Bio Announces Pricing of $4 Million Public Offering

GlobeNewswire

3 months ago

Mustang Bio Announces Pricing of $4 Million Public Offering

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

GlobeNewswire

3 months ago

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire

3 months ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Avenue Therapeutics Announces Reverse Stock Split

GlobeNewswire

3 months ago

Avenue Therapeutics Announces Reverse Stock Split

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

GlobeNewswire

4 months ago

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

GlobeNewswire

4 months ago

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

GlobeNewswire

4 months ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

GlobeNewswire

4 months ago

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire

4 months ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

GlobeNewswire

4 months ago

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire

4 months ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Fortress Biotech to Participate in 36th Annual ROTH Conference

GlobeNewswire

4 months ago

Fortress Biotech to Participate in 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

GlobeNewswire

5 months ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

GlobeNewswire

5 months ago

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

GlobeNewswire

5 months ago

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

GlobeNewswire

5 months ago

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

GlobeNewswire

5 months ago

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

Insider Stock Buying Reaches US$3.06m On Fortress Biotech

Simply Wall St.

5 months ago

Insider Stock Buying Reaches US$3.06m On Fortress Biotech

Microsoft, Tesla, Netflix, and More: Big Names in the Market Worth Talking About

Motley Fool

6 months ago

Microsoft, Tesla, Netflix, and More: Big Names in the Market Worth Talking About

Coach says Japan must improve in 'many aspects' after Asian Cup exit

AFP

6 months ago

Coach says Japan must improve in 'many aspects' after Asian Cup exit

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

News Direct

6 months ago

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

GlobeNewswire

6 months ago

Lakeshore Acquisition II Corp. Announces Effectiveness of Registration Statement and Date for General Meeting to Approve Proposed Business Combination with Nature’s Miracle

Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market

GlobeNewswire

6 months ago

Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55

SmartAsset

6 months ago

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55

GG.BET and Team Vitality are extending their partnership into 2024

PR Newswire

6 months ago

GG.BET and Team Vitality are extending their partnership into 2024

Bad Ass Coffee of Hawaii Hits Winning Stride with Unwavering Franchise Growth and Strong Sales Performance

PR Newswire

6 months ago

Bad Ass Coffee of Hawaii Hits Winning Stride with Unwavering Franchise Growth and Strong Sales Performance

Avanti Senior Living Partners with Icon to Enhance Residents’ Experience By Leveraging Cutting-Edge Technology

Business Wire

6 months ago

Avanti Senior Living Partners with Icon to Enhance Residents’ Experience By Leveraging Cutting-Edge Technology

Business Wire

6 months ago

Issue of Debt

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

6 months ago

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

King Charles III spends third day in London hospital after prostate surgery

AFP

6 months ago

King Charles III spends third day in London hospital after prostate surgery

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

Motley Fool

6 months ago

20 "Tech" Stocks Make Up Over 35% of the S&P 500. Here's What That Means for Your Portfolio.

Whether or not the Fed cuts rates is not the right question

Yahoo Finance

6 months ago

Whether or not the Fed cuts rates is not the right question

Bitcoin ETFs Are Here. Why You Should Buy and Hold Long Term

Motley Fool

6 months ago

Bitcoin ETFs Are Here. Why You Should Buy and Hold Long Term

Biotech’s First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks.

Barrons.com

6 months ago

Biotech’s First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks.

GlobeNewswire

6 months ago

Automatic Self-cleaning Cat Litter Box Market to Hit US$ 1,262.7 Million by 2030 | Updated Insights Report by Persistence Market Research

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions

GlobeNewswire

6 months ago

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions

GlobeNewswire

6 months ago

Viscosupplementation Market Predicted to Hit US$ 13.6 Billion in 2032, Riding on a Strong 10.8% CAGR | According to Persistence Market Research

Countdown to Heartland Financial (HTLF) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks

6 months ago

Countdown to Heartland Financial (HTLF) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Meta Materials Announces 1-for-100 Reverse Stock Split to Regain Nasdaq Compliance

ACCESSWIRE

6 months ago

Meta Materials Announces 1-for-100 Reverse Stock Split to Regain Nasdaq Compliance

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

GlobeNewswire

6 months ago

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

The Electric Pickup Concept Will Continue To Evolve In 2024

Benzinga

6 months ago

The Electric Pickup Concept Will Continue To Evolve In 2024

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

6 months ago

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

6 months ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire

6 months ago

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

GuruFocus.com

7 months ago

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

$572 Million Business Combination Between Braiin and Northern Revival Acquisition Corporation (Nasdaq: NRAC) Has Been Proposed and Form F-4 Jointly Filed With SEC

Business Wire

7 months ago

$572 Million Business Combination Between Braiin and Northern Revival Acquisition Corporation (Nasdaq: NRAC) Has Been Proposed and Form F-4 Jointly Filed With SEC

Is AdTheorent Holding Company, Inc.'s (NASDAQ:ADTH) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Simply Wall St.

7 months ago

Is AdTheorent Holding Company, Inc.'s (NASDAQ:ADTH) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

GlobeNewswire

7 months ago

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

GlobeNewswire

7 months ago

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

Lottery.com Inc. Announces $18 Million Commitment from Prosperity Investment Management

GlobeNewswire

7 months ago

Lottery.com Inc. Announces $18 Million Commitment from Prosperity Investment Management

Actelis Receives Order For Networking Of Traffic Management and Safety IoT Applications In The City of Everett, Washington

GlobeNewswire

8 months ago

Actelis Receives Order For Networking Of Traffic Management and Safety IoT Applications In The City of Everett, Washington

Complete Solaria Announces Will Anderson to Remain Interim CEO

GlobeNewswire

8 months ago

Complete Solaria Announces Will Anderson to Remain Interim CEO

RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market

PR Newswire

8 months ago

RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for

Zacks

8 months ago

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for

It's Down 28% But Science 37 Holdings, Inc. (NASDAQ:SNCE) Could Be Riskier Than It Looks

Simply Wall St.

8 months ago

It's Down 28% But Science 37 Holdings, Inc. (NASDAQ:SNCE) Could Be Riskier Than It Looks

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q3 2023 Earnings Call Transcript

GuruFocus.com

9 months ago

Microvast Holdings Inc Reports Substantial Year-Over-Year Growth in Q3 2023

YieldMax™ ETFs Announces Monthly Distributions on AMDY (65.22%), CONY (58.23%), TSLY (57.79%), DISO (42.66%), PYPY (38.82%) and Others

GlobeNewswire

9 months ago

YieldMax™ ETFs Announces Monthly Distributions on AMDY (65.22%), CONY (58.23%), TSLY (57.79%), DISO (42.66%), PYPY (38.82%) and Others

Brookdale to Present at the 2023 Stephens Annual Investment Conference

PR Newswire

9 months ago

Brookdale to Present at the 2023 Stephens Annual Investment Conference

Share on Social Networks: